Back

Efficacy and safety aspects of renal denervation in treatment of arterial hypertension: a systematic review and meta-analysis

27 August 2023 (17:05 - 17:15)
Organised by: Logo
Congress Presentation Part of: What’s new in hypertension? Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Davor Vukadinovic

Saarland University Hospital, Homburg (Germany)

2 More presentations in this session

Presentation thumbnail
MyD88 in myeloid cells promotes angiotensin II-induced vascular inflammation and is associated with all-cause mortality and incident heart failure in humans with arterial hypertension
Mr P. Wenzel (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Sympathetic nerve activity reactivity is associated with cardiac fibrosis in humans
Ms H. Blythe (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
What’s new in hypertension?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Renal denervation is one of the pillars of management of resistant hypertension: pro
thumbnail
Congress Presentation
Assessing the efficacy of renal denervation in patients with resistant arterial hypertension: a systematic review and meta-analysis
thumbnail
Congress Presentation
New guidelines and expert consensus on renal denervation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources